Drug Profile
Research programme: Campylobacter jejuni/Escherichia coli Vaccines - TD Vaccines
Alternative Names: ACE 920Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator ACE BioSciences
- Developer TD Vaccines A/S; Zymenex A/S
- Class Bacterial vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Traveller's diarrhoea
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Traveller's-diarrhoea(Prevention) in Netherlands (PO)
- 09 Nov 2009 Preclinical trials in Traveller's diarrhoea in Netherlands (PO)